Onset of vitiligo following targeted therapy for BRAF(V600E)-mutated melanoma: case report

Systemic treatment for metastatic melanoma has advanced dramatically in recent years with an impressive increase in the rate of overall survival. The two main different strategies are targeted therapies (i.e. BRAF and MEK inhibitors) and immunotherapy with monoclonal antibodies against the immune ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Brugnara, Sonia, Sicher, Mariacristina, Bonandini, Elena Maria, Barbareschi, Mattia, Girardelli, Carlo Renè, Caffo, Orazio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048152/
https://www.ncbi.nlm.nih.gov/pubmed/32158480
http://dx.doi.org/10.7573/dic.212582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048152/
https://www.ncbi.nlm.nih.gov/pubmed/32158480
http://dx.doi.org/10.7573/dic.212582

Ejemplares similares